Hemostemix PR Inc. Congratulates Luis Muñoz Marín International Airport on Achieving CEIV Pharma Certification Read More
Hemostemix’s 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease Read More
HEMOSTEMIX ANNOUNCES ACP-01 TREATMENT-PURCHASE AVAILABLE WITH SOCIAL MEDIA CAMPAIGN UNDERWAY Read More
Hemostemix Announces the Incorporation of PreCerv Inc. and a Global Field of Use License to NCP-01 Read More
Investor Relations Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% reimbursement of R&D expenses in cash Read More
